Although all wild-type bacterial populations exhibit antibiotic tolerance, bacterial mutants with higher or lower tolerant subpopulation sizes have been described. We recently showed that in mycobacteria, phenotypically-resistant subpopulations can grow in bulk-lethal concentrations of rifampicin, a first-line anti-tuberculous antibiotic targeting RNA polymerase. Phenotypic resistance was partly mediated by paradoxical upregulation of RNA polymerase in response to rifampicin. However, naturally occurring mutations that increase tolerance via this mechanism had not been previously described. Here, we used transposon insertional mutagenesis and deep sequencing (Tnseq) to investigate rifampicin-specific phenotypic resistance using two different in vitro models of rifampicin tolerance in Mycobacterium smegmatis. We identify multiple genetic factors that mediate susceptibility to rifampicin. Disruption of one gene, lepA, a translation-associated elongation factor, increased rifampicin tolerance in all experimental conditions. Deletion of lepA increased the subpopulation size that is able to grow in bulklethal rifampicin concentrations via upregulation of basal rpoB expression. Moreover, homologous mutations in lepA that are found in clinical Mycobacterium tuberculosis (Mtb) isolates phenocopy lepA deletion to varying degrees. Our study identifies multiple genetic factors associated with rifampicin tolerance in mycobacteria, and may allow correlation of genetic diversity of clinical Mtb isolates with clinically important phenotypes such as treatment regimen duration. Antibiotic tolerance describes genetically susceptible bacterial subpopulations that are killed more slowly than the bulk population 1,2. There are a spectrum of phenotypes associated with antibiotic tolerance 3. The best studied is non-replicating persistence-in which non-or slowly-replicating bacteria are typically multi-drug tolerant 1. However, increasing evidence, particularly in mycobacteria, suggests that actively replicating bacteria can also be highly drug tolerant 4-9. We have previously focused on tolerance in actively growing cells to the first-line anti-tuberculous antibiotic rifampicin, which inhibits RNA polymerase (RNAP), and which we termed rifampicin-specific phenotypic resistance (RSPR). We observed that mycobacteria can not only survive, but actively grow in bulk-lethal concentrations of rifampicin. Both specific translational errors involving the indirect tRNA aminoacylation pathway, as well as a paradoxical upregulation of rpoB in response to rifampicin mediated RSPR 7,9,10. Importantly, both mechanisms of RSPR were confirmed in clinical isolates of Mycobacterium tuberculosis (Mtb), corroborating the potential clinical relevance of this form of antibiotic tolerance 7,9. Transposon insertion mutagenesis and deep sequencing (Tnseq) has proven a valuable tool for forward genetics in bacteria. Although it has been used extensively for identification of genetic factors involved in bacterial physiology, host-pathogen interactions, as well a...